ACCESS Newswire
Orlando Dreamers Announce Addition of MLB All-Star Johnny Damon as MLB Strategic Advisor
📈
AI Sentiment
Highly Positive
9/10
- Home
- HUMAW
HUMAW
Humacyte Inc. Warrant
as of 01-02-2026 3:48pm EST
$0.09
$0.01
-5.34%
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.
| Founded: | 2004 | Country: | United States |
| Employees: | 220 | City: | DURHAM |
| Market Cap: | N/A | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 14.2K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.18 - $1.34 | Next Earning Date: | 03-21-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Humacyte Inc. Warrant News
HUMAW Breaking Stock News: Dive into HUMAW Ticker-Specific Updates for Smart Investing
ACCESS Newswire
NOA Lithium Announces Issuance of Stock Options
GuruFocus.com
Exchanges Decline to List Tuttle Capital's GRFT ETF Despite SEC Effectiveness
➖
AI Sentiment
Neutral
4/10
Investing.com
SoftBank completes $40 billion investment in OpenAI, CNBC says
📈
AI Sentiment
Highly Positive
10/10
Investor's Business Daily
This Company Just Announced Long-Term Contracts For Nuclear Power Amid Rosy Outlook For This Commodity
📈
AI Sentiment
Highly Positive
8/10
Compare HUMAW vs Leading Stocks
See how HUMAW stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "HUMAW Humacyte Inc. Warrant - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.